Literature DB >> 6086253

Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.

J S Albaugh, E B Keeffe, W W Krippaehne.   

Abstract

A 24-year-old man with hepatocellular carcinoma presented with recurrent obstructive jaundice caused by bile duct invasion and distal migration of necrotic tumor fragments. After resection of an isolated left lobe tumor, he was well for 2 years until he again presented with obstructive jaundice caused by necrotic tumor and clot in the common bile duct. Analysis of his tumor revealed the fibrolamellar histologic variant of hepatocellular carcinoma. This case is unique in that the hepatocellular carcinoma was of the fibrolamellar variant and presented both initially and when recurrent 2 years later with obstructive jaundice caused by invasion of the common bile duct.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086253     DOI: 10.1007/bf01312952

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Bile duct obstruction in hepatocellular carcinoma (hepatoma)--clinical and cholangiographic characteristics. Report of 6 cases and review of the literature.

Authors:  E vanSonnenberg; J T Ferrucci
Journal:  Radiology       Date:  1979-01       Impact factor: 11.105

2.  Obstructive jaundice caused by hepatocellular carcinoma. Report of three cases.

Authors:  A Afroudakis; S M Bhuta; K A Ranganath; N Kaplowitz
Journal:  Am J Dig Dis       Date:  1978-07

3.  Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Authors:  L K Wong; D P Link; C F Frey; R H Ruebner; H Tesluk; N R Pimstone
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

4.  The histopathologic and clinical indicators of prognosis in hepatoma.

Authors:  J J Chuong; E M Livstone; K W Barwick
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

5.  Hepatocellular carcinoma. Polygonal cell type with fibrous stroma--an atypical variant with a favorable prognosis.

Authors:  M M Berman; N P Libbey; J H Foster
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

6.  Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases.

Authors:  M Kojiro; K Kawabata; Y Kawano; F Shirai; N Takemoto; T Nakashima
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

7.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

8.  Case report. Hepatocellular carcinoma with lamellar fibrosis: an important histological variant.

Authors:  L J Slavutin; N Diamond
Journal:  Pathology       Date:  1981-10       Impact factor: 5.306

9.  Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence.

Authors:  E E Lack; C Neave; G F Vawter
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

10.  Hepatocellular carcinoma in young people.

Authors:  D C Farhi; R H Shikes; P J Murari; S G Silverberg
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

View more
  5 in total

Review 1.  Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature.

Authors:  S Saab; F Yao
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

2.  Percutaneous transhepatic microwave coagulation therapy for hepatocellular carcinoma proliferating in the bile duct.

Authors:  T Seki; Y Kubota; M Wakabayashi; K Kunieda; S Nakatani; T Shiro; K Inoue
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

3.  Intrahepatic bile duct dilatation secondary to hepatocellular carcinoma: CT features in 10 patients.

Authors:  P Soyer; A Sibert; J P Laissy
Journal:  Abdom Imaging       Date:  1995 Mar-Apr

Review 4.  Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.

Authors:  Walaa Abdelhamed; Mohamed El-Kassas
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

Review 5.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.